Search Results

There are 2849402 results for: content related to: Low rate of bone density testing in men receiving androgen deprivation therapy

  1. Sexual Function in Elderly Men Receiving Androgen Deprivation Therapy (ADT)

    Sexual Medicine Reviews

    Volume 2, Issue 1, January 2014, Pages: 36–46, Mikkel Fode and Jens Sønksen

    Version of Record online : 17 DEC 2013, DOI: 10.1002/smrj.17

  2. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners


    Volume 121, Issue 24, December 15, 2015, Pages: 4286–4299, Kristine A. Donovan, Lauren M. Walker, Richard J. Wassersug, Lora M. A. Thompson and John W. Robinson

    Version of Record online : 15 SEP 2015, DOI: 10.1002/cncr.29672

  3. You have full text access to this OnlineOpen article
    Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer

    International Journal of Clinical Practice

    Volume 69, Issue 1, January 2015, Pages: 106–123, I. D. White, J. Wilson, P. Aslet, A. B. Baxter, A. Birtle, B. Challacombe, J. Coe, L. Grover, H. Payne, S. Russell, V. Sangar, N. Van As and M. Kirby

    Version of Record online : 5 OCT 2014, DOI: 10.1111/ijcp.12512

  4. You have free access to this content
    Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy


    Volume 119, Issue 4, 15 February 2013, Pages: 863–870, Alicia K. Morgans, Matthew R. Smith, A. James O'Malley and Nancy L. Keating

    Version of Record online : 12 OCT 2012, DOI: 10.1002/cncr.27830

  5. You have free access to this content
    Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

    CA: A Cancer Journal for Clinicians

    Volume 60, Issue 3, May/June 2010, Pages: 194–201, Glenn N. Levine, Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I. Sagalowsky, Matthew R. Smith and Neil Zakai

    Version of Record online : 3 FEB 2010, DOI: 10.3322/caac.20061

  6. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life

    The Journal of Sexual Medicine

    Volume 7, Issue 9, September 2010, Pages: 2996–3010, Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson and the ADT Survivorship Working Group

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1743-6109.2010.01902.x

  7. You have free access to this content
    Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience

    BJU International

    Volume 104, Issue 9, November 2009, Pages: 1208–1214, Christopher J. DiBlasio, John B. Malcolm, Jessica Hammett, Jim Y. Wan, Michael A. Aleman, Anthony L. Patterson, Robert W. Wake and Ithaar H. Derweesh

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08593.x

  8. Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer


    Konstantin A. Kovtun, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran and Anthony V. D'Amico

    Version of Record online : 4 AUG 2016, DOI: 10.1002/cncr.30224

  9. You have free access to this content
    Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth

    Journal of Andrology

    Volume 29, Issue 5, September-October 2008, Pages: 534–539, Shehzad Basaria

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.108.005454

  10. You have free access to this content
    A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 924–928, Howard S. Kim, Daniel M. Moreira, Matthew R. Smith, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 22 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09679.x

  11. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison


    Volume 24, Issue 4, April 2015, Pages: 472–477, Morgan Lee, Heather S. Jim, Mayer Fishman, Babu Zachariah, Randy Heysek, Matthew Biagioli and Paul B. Jacobsen

    Version of Record online : 13 JUN 2014, DOI: 10.1002/pon.3608

  12. You have free access to this content
    Information needs of men on androgen deprivation therapy

    BJU International

    Volume 109, Issue 10, May 2012, Pages: 1503–1509, Tony Soeyonggo, Padraig Warde, Neil Fleshner, Narhari Timilshina and Shabbir M.H. Alibhai

    Version of Record online : 24 AUG 2011, DOI: 10.1111/j.1464-410X.2011.10475.x

  13. Quality of Life in Prostate Cancer Patients Taking Androgen Deprivation Therapy

    Journal of the American Geriatrics Society

    Volume 54, Issue 1, January 2006, Pages: 85–90, Kirsten Dacal, Susan M. Sereika and Susan L. Greenspan

    Version of Record online : 2 DEC 2005, DOI: 10.1111/j.1532-5415.2005.00567.x

  14. You have free access to this content
    Androgen deprivation therapy: evidence-based management of side effects

    BJU International

    Volume 111, Issue 4, April 2013, Pages: 543–548, Hamed Ahmadi and Siamak Daneshmand

    Version of Record online : 25 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11774.x

  15. You have free access to this content
    Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy


    Volume 101, Issue 3, 1 August 2004, Pages: 541–549, Tracey L. Krupski, Matthew R. Smith, Won Chan Lee, Chris L. Pashos, Jane Brandman, Qin Wang, Marc Botteman and Mark S. Litwin

    Version of Record online : 21 JUN 2004, DOI: 10.1002/cncr.20388

  16. Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review

    European Journal of Clinical Investigation

    Volume 45, Issue 5, May 2015, Pages: 475–484, Matthew L. Romo, Aileen M. McCrillis, Jennifer Brite, Dalicia Reales, Jennifer B. Dowd and C. Mary Schooling

    Version of Record online : 27 APR 2015, DOI: 10.1111/eci.12431

  17. You have free access to this content
    Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer

    Journal of Medical Imaging and Radiation Oncology

    Volume 58, Issue 2, April 2014, Pages: 223–228, David Chang, David J Joseph, Martin A Ebert, Daniel A Galvão, Dennis R Taaffe, James W Denham, Robert U Newton and Nigel A Spry

    Version of Record online : 7 OCT 2013, DOI: 10.1111/1754-9485.12124

  18. Monitoring cardiovascular health in men with prostate cancer treated with androgen deprivation therapy

    International Journal of Urological Nursing

    Volume 6, Issue 1, March 2012, Pages: 35–41, Carolyn A Allan, Veronica R Collins, Mark Frydenberg, Robert I McLachlan and Kati L Matthiesson

    Version of Record online : 20 FEB 2012, DOI: 10.1111/j.1749-771X.2011.01135.x

  19. You have free access to this content
    Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 13–21, C. Schulman, J. Irani and M. Aapro

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11216.x

  20. You have free access to this content
    Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

    BJU International

    Volume 111, Issue 5, May 2013, Pages: 745–752, Yu-Hsuan Shao, Dirk F. Moore, Weichung Shih, Yong Lin, Thomas L. Jang and Grace L. Lu-Yao

    Version of Record online : 17 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11758.x